144-14-9 Usage
Uses
Used in Pharmaceutical Industry:
Anileridine is used as an analgesic agent for its potent pain-relieving properties. It is particularly effective in managing moderate to severe pain due to its increased analgesic activity compared to other drugs in its class.
Used in Pain Management:
Anileridine is used as a pain management medication for various conditions that cause acute or chronic pain. Its high efficacy in alleviating pain makes it a valuable option for patients seeking relief from discomfort and distress.
Used in Research and Development:
Anileridine is also utilized in the research and development of new pharmaceuticals, particularly in the field of analgesics. Its unique chemical structure and properties provide valuable insights for the development of more effective and safer pain-relieving drugs.
Therapeutic Function
Narcotic analgesic
Safety Profile
Poison by ingestion,subcutaneous, intravenous, and intraperitoneal routes.When heated to decomposition it emits toxic fumes ofNOx.
Check Digit Verification of cas no
The CAS Registry Mumber 144-14-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,4 and 4 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 144-14:
(5*1)+(4*4)+(3*4)+(2*1)+(1*4)=39
39 % 10 = 9
So 144-14-9 is a valid CAS Registry Number.
InChI:InChI=1/C22H28N2O2/c1-2-26-21(25)22(19-6-4-3-5-7-19)13-16-24(17-14-22)15-12-18-8-10-20(23)11-9-18/h3-11H,2,12-17,23H2,1H3
144-14-9Relevant academic research and scientific papers
Brain-specific analogues of centrally acting amines
-
, (2008/06/13)
The subject compounds, which are adapted for the site-specific/sustained delivery of centrally acting drug species to the brain, are compounds of the formula STR1 and the non-toxic pharmaceutically acceptable salts thereof, wherein D is the residue of a centrally acting primary, secondary or tertiary amine and STR2 is an unsubstituted or substituted dihydropyridyl, dihydroquinolyl or dihydroisoquinolyl radical. The corresponding ionic pyridinium, quinolinium and isoquinolinium salts STR3 X-, wherein X- is the anion of a non-toxic pharmaceutically acceptable acid, are also disclosed.